Abstract
Purpose: To determine the usefulness of perfusion weighted MR imaging in the assessment of relative cerebral blood volume(rCBV) in brain tumors. Materials and Methods: Twenty-three patients with primary or metastatic brain tumors [nine gliomas (6 high grade and 3 low), six metastatic tumors, five meningiomas (4 benign and 1 atypical), two neurilemmomas and one hemangioblastoma] underwent perfusion-weighted and conventional MR imaging. A total of 240 perfusion MR images were obtained from four axial slices after rapid injection of contrast media using a gradient echo planar imaging pulse sequence, and this was followed by postprocessing of these images to give CBV maps. In order to calculate the rCBV of tumor to normal white matter, ROIs were defined on the CBV map of a tumor and its contralateral normal white matter. Results: The rCBV ratio of tumors to contralateral normal side was as follows: high-grade glioma, 0.40-5.64(meanSD = 2.910.95); low grade astrocytoma, 0.77 -1.66 (meanSD = 1.150.28); benign menin-gioma,2.06 -4.90 (meanSD = 3.590.84); atypical meningioma, 0.46 -1.18 (meanSD = 0.720.25); neurilemmoma, 1.45 -3.85 (meanSD = 2.560.92); and hemangioblastoma, 6.16 -8.35 (meanSD = 7.021.12). High grade gliomas were more hypervascular than low grade astrocytomas, and showed a variable range of relative cerebral blood volume. In metaststic cancer, CBV maps showed a relatively high and variable blood volume. Benign meningiomas exhibited high relative cerebral blood volume, while in the atypical menin-gioma with cystic degeneration, this volume was low. In neurilemmomas, a variable range of relative cerebral blood volume, was noted, while in the mural nodule of the hemangioblastoma, this volume was the highest. Conclusion: Perfusion-weighted MRI indicated the rCBV of various brain tumor lesions, and this suggests that the modality can provide a very useful means of assessing brain tumor vascularity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.